VK

Vivek Kumar Rana

Director Director DIN 08789336
DIN 08789336 First appointment Sep 2023 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Sep 2023
Shareholding value Locked Premium profile

About Vivek Kumar Rana

Data last updated:

Vivek Kumar Rana has 3 years in corporate governance. Formerly with 1 company, such as Medicef Pharma Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08789336
Primary Designation Director
First Appointment 25 Sep 2023
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Medicef Pharma Limited U24100HP2012PLC011243
Director25 Sep 20232012Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medicef Pharma Limited
Premium access

Shareholding and investment profile for Vivek Kumar Rana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Kumar Rana

Vivek Kumar Rana has 3 years in corporate governance. Formerly with 1 company, such as Medicef Pharma Limited. Engaged in General Business. Contributes to corporate operations.

Vivek Kumar Rana is associated with 0 companies as a director.

Vivek Kumar Rana has expertise in General Business.

Vivek Kumar Rana has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available